Get started
Author

Jennifer B. Shannon

Observed names: J B Shannon, J Shannon, Jennifer B Shannon, Jennifer Shannon
Observed institutions: Brigham and Women's Hospital, Novartis (Switzerland), Amgen (United States), GlaxoSmithKline (United Kingdom), GlaxoSmithKline (United States), PAREXEL International (United States), Thrombolysis in Myocardial Infarction Study Group
ORCID: 0009-0001-7266-2295
Observed ORCID: 0009-0001-7266-2295
OpenAlex ID: A5032802152
Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome
2014 · Michelle L. O’Donoghue, Eugene Braunwald, et al. · JAMA · 462
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction
2016 · Michelle L. O’Donoghue, Ruchira Glaser, et al. · JAMA · 252
PDF
The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia
2006 · R Wurzel, P Ray, et al. · Prostate Cancer and Prostatic Diseases · 66
Effect of Dutasteride on Intraprostatic Androgen Levels in Men With Benign Prostatic Hyperplasia or Prostate Cancer
2008 · Roger Rittmaster, Robert G. Hahn, et al. · Urology · 63
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
2025 · Gideon M Hirschfield, Christopher L Bowlus, et al. · The Lancet. Gastroenterology & hepatology · 45
Daprodustat and Heart Failure in CKD
2024 · Jonathan W. Cunningham, Brian L. Claggett, et al. · Journal of the American Society of Nephrology · 24
GS-011 Linerixibat significantly improves cholestatic pruritus in primary biliary cholangitis: results of the pivotal phase 3 GLISTEN trial
2025 · Gideon M. Hirschfield, Christopher L. Bowlus, et al. · Journal of Hepatology · 5
O8 Linerixibat significantly improves cholestatic pruritus in primary biliary cholangitis (PBC): results of the pivotal phase 3 GLISTEN trial
2025 · Gideon Hirshfield, Christopher Bowlus, et al. · Gut · 2
TOP-280 Long-term safety, tolerability and maintenance of efficacy of linerixibat for the treatment of cholestatic pruritus in primary biliary cholangitis
2026 · Christopher L. Bowlus, Stuart C Gordon, et al. · Journal of Hepatology · 1
1635: Inhibition of Type I and Type II Sa-Reductase with Dutasteride (0.5 mg) Significantly Reduces Intraprostatic Dihydrotestosterone in BPH Patients
2006 · Rafael Wurzel, Paul Ray, et al. · The Journal of Urology · 1
Understanding linerixibat as a treatment for itch in people with primary biliary cholangitis: a plain language summary of the GLISTEN trial
2026 · Gideon M. Hirschfield, Brooke M. Currie, et al. · Future Rare Diseases
PDF
Impact of linerixibat on pharmacodynamic biomarkers and mediators of cholestatic pruritus in primary biliary cholangitis (PBC) in the Phase 3 GLISTEN study
2026 · A E Kremer, S Hohenester, et al. · Zeitschrift für Gastroenterologie
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
2026 · Gideon M. Hirschfield, Christopher L. Bowlus, et al. · Newcastle University ePrints (Newcastle Univesity)
Linerixibat significantly improves cholestatic pruritus in primary biliary cholangitis: results of the pivotal Phase 3 GLISTEN trial
2025 · G M Hirschfield, C L Bowlus, et al. · Zeitschrift für Gastroenterologie
Mo1623: EARLY PRESENTATION AND UNDERTREATMENT OF CHOLESTATIC PRURITUS IN PRIMARY BILIARY CHOLANGITIS (PBC): INSIGHTS FROM THE PHASE 3 GLISTEN TRIAL BASELINE DATA
2025 · Marlyn J. Mayo, Gideon Hirschfield, et al. · Gastroenterology
Insufficient control of cholestatic pruritus in primary biliary cholangitis (PBC) with current therapies: baseline data from the ongoing Phase 3 GLISTEN (Global Linerixibat Itch STudy of Efficacy and safety iN PBC) trial
2025 · Gideon M. Hirschfield, Christopher L. Bowlus, et al. · Zeitschrift für Gastroenterologie
Hemoglobin Stability in the ASCEND-TD Trial
2023 · Anjali Acharya, Anjay Rastogi, et al. · Journal of the American Society of Nephrology
#3807 Heart Failure in Ascend-nd and Ascend-d
2023 · Ajay K Singh, Brian L Claggett, et al. · Nephrology Dialysis Transplantation
PDF
#3715 the Effect of Daprodustat on Intravenous Iron Use in Patients With Ckd-related Anaemia on Dialysis in the Ascend Trials
2023 · Pablo Pergola, Tomas Ganz, et al. · Nephrology Dialysis Transplantation
PDF
#3704 Eu Region-specific Cardiovascular Event Data for Daprodustat in Ascend-d and Ascend-nd
2023 · David C Wheeler, Aleix Cases Amenos, et al. · Nephrology Dialysis Transplantation
PDF
Performance Reports and the Utilization of Guideline-based Therapies in a Large Clinical Trial Population Enrolled After an Acute Coronary Syndrome: Insights From the Solid-timi 52 Trial
2015 · Dylan Steen, Christopher Cannon, et al. · Journal of the American College of Cardiology
PDF
Design, Summarization, Analysis, and Interpretation of Cancer Prevention Trials
2009 · Jennifer Shannon, Timothy Wilson, et al. · Chapman & Hall/CRC eBooks
Works count: 22
Citation count: 921
H-index: 6
I10-index: 6
Year
Topic
Type